{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T12:06:50Z","timestamp":1791634010974,"version":"4.3.4"},"reference-count":221,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.pharmr.2025.100072","type":"journal-article","created":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T20:12:29Z","timestamp":1749154349000},"page":"100072","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Fibroblasts\u2014The emerging therapeutic target of the cardiovascular system?"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8983-5359","authenticated-orcid":false,"given":"Sebastiaan E.J.","family":"Asselberghs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2386-9684","authenticated-orcid":false,"given":"Maurice","family":"Halder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4048-6351","authenticated-orcid":false,"given":"Rafael","family":"Kramann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0269-4582","authenticated-orcid":false,"given":"Judith C.","family":"Sluimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.pharmr.2025.100072_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib2","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41569-022-00805-7","article-title":"Single-cell transcriptomics for the assessment of cardiac disease","volume":"20","author":"Miranda","year":"2023","journal-title":"Nat Rev Cardiol"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100072_bib3","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/j.ccell.2024.08.020","article-title":"Cross-tissue human fibroblast atlas reveals myofibroblast subtypes with distinct roles in immune modulation","volume":"42","author":"Gao","year":"2024","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib4","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.cell.2019.05.010","article-title":"The translational landscape of the human heart","volume":"178","author":"van Heesch","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41569-019-0155-8","article-title":"Mechanical regulation of gene expression in cardiac myocytes and fibroblasts","volume":"16","author":"Saucerman","year":"2019","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ygeno.2014.12.002","article-title":"RNA-Seq identifies novel myocardial gene expression signatures of heart failure","volume":"105","author":"Liu","year":"2015","journal-title":"Genomics"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.87623","article-title":"PIK3CA-associated developmental disorders exhibit distinct classes of mutations with variable expression and tissue distribution","volume":"1","author":"Mirzaa","year":"2016","journal-title":"JCI Insight"},{"issue":"14","key":"10.1016\/j.pharmr.2025.100072_bib8","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1093\/eurheartj\/ehac686","article-title":"Translational opportunities of single-cell biology in atherosclerosis","volume":"44","author":"de Winther","year":"2023","journal-title":"Eur Heart J"},{"issue":"21","key":"10.1016\/j.pharmr.2025.100072_bib9","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1161\/CIRCULATIONAHA.120.048378","article-title":"Single-cell genomics reveals a novel cell state during smooth muscle cell phenotypic switching and potential therapeutic targets for atherosclerosis in mouse and human","volume":"142","author":"Pan","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib10","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/s41591-019-0512-5","article-title":"Atheroprotective roles of smooth muscle cell phenotypic modulation and the TCF21 disease gene as revealed by single-cell analysis","volume":"25","author":"Wirka","year":"2019","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100072_bib11","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1093\/cvr\/cvad016","article-title":"Human and murine fibroblast single-cell transcriptomics reveals fibroblast clusters are differentially affected by ageing and serum cholesterol","volume":"119","author":"van Kuijk","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.pharmr.2025.100072_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.973070","article-title":"Cellular heterogeneity in disease severity and clinical outcome: granular understanding of immune response is key","volume":"13","author":"Khare","year":"2022","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib13","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1096\/fj.201903188R","article-title":"Origin and functional heterogeneity of fibroblasts","volume":"34","author":"LeBleu","year":"2020","journal-title":"FASEB J"},{"issue":"15","key":"10.1016\/j.pharmr.2025.100072_bib14","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.1016\/j.cell.2021.06.024","article-title":"Fibroblasts: origins, definitions, and functions in health and disease","volume":"184","author":"Plikus","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.pharmr.2025.100072_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102296","article-title":"Tissue fibroblasts are versatile immune regulators: an evaluation of their impact on the aging process","volume":"97","author":"Salminen","year":"2024","journal-title":"Ageing Res Rev"},{"issue":"7860","key":"10.1016\/j.pharmr.2025.100072_bib16","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-021-03549-5","article-title":"Cross-tissue organization of the fibroblast lineage","volume":"593","author":"Buechler","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.diff.2016.05.008","article-title":"The origin of renal fibroblasts\/myofibroblasts and the signals that trigger fibrosis","volume":"92","author":"Sun","year":"2016","journal-title":"Differentiation"},{"key":"10.1016\/j.pharmr.2025.100072_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109869","article-title":"Diverse origins and activation of fibroblasts in cardiac fibrosis","volume":"78","author":"Aujla","year":"2021","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmr.2025.100072_bib19","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.24803.1","article-title":"Cell plasticity in cancer cell populations","volume":"9","author":"Shen","year":"2020","journal-title":"F1000Res"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib20","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1016\/j.celrep.2020.02.008","article-title":"Dynamic interstitial cell response during myocardial infarction predicts resilience to rupture in genetically diverse mice","volume":"30","author":"Forte","year":"2020","journal-title":"Cell Rep"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib21","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.119.045401","article-title":"Transcriptional and cellular diversity of the human heart","volume":"142","author":"Tucker","year":"2020","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/cvr\/cvaa320","article-title":"Heart regeneration: beyond new muscle and vessels","volume":"117","author":"Sayers","year":"2021","journal-title":"Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41569-021-00587-4","article-title":"Genomic frontiers in congenital heart disease","volume":"19","author":"Morton","year":"2022","journal-title":"Nat Rev Cardiol"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib24","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1242\/dev.079970","article-title":"The bHLH transcription factor Tcf21 is required for lineage-specific EMT of cardiac fibroblast progenitors","volume":"139","author":"Acharya","year":"2012","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/BF00310051","article-title":"Origin and development of the epicardium in the mouse embryo","volume":"176","author":"Komiyama","year":"1987","journal-title":"Anat Embryol (Berl)"},{"key":"10.1016\/j.pharmr.2025.100072_bib26","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1038\/ncomms2978","article-title":"Haemodynamically dependent valvulogenesis of zebrafish heart is mediated by flow-dependent expression of miR-21","volume":"4","author":"Banjo","year":"2013","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3390\/jcm5020027","article-title":"Epicardial epithelial-to-mesenchymal transition in heart development and disease","volume":"5","author":"Krainock","year":"2016","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib28","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1161\/CIRCRESAHA.119.315857","article-title":"The role of the epicardium during heart development and repair","volume":"126","author":"Quijada","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100072_bib29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.yjmcc.2013.10.005","article-title":"Differential expression of embryonic epicardial progenitor markers and localization of cardiac fibrosis in adult ischemic injury and hypertensive heart disease","volume":"65","author":"Braitsch","year":"2013","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib30","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1161\/CIRCRESAHA.110.235531","article-title":"Epicardial-derived cell epithelial-to-mesenchymal transition and fate specification require PDGF receptor signaling","volume":"108","author":"Smith","year":"2011","journal-title":"Circ Res"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib31","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1161\/CIRCRESAHA.111.259960","article-title":"Endocardial and epicardial epithelial to mesenchymal transitions in heart development and disease","volume":"110","author":"von Gise","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100072_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.pharmr.2025.100072_bib33","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yjmcc.2017.11.012","article-title":"Resident fibroblast expansion during cardiac growth and remodeling","volume":"114","author":"Ivey","year":"2018","journal-title":"J Mol Cell Cardiol"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib34","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a005058","article-title":"Extracellular matrix degradation and remodeling in development and disease","volume":"3","author":"Lu","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib35","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/CIRCRESAHA.114.302533","article-title":"Myocardial extracellular matrix: an ever-changing and diverse entity","volume":"114","author":"Rienks","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.pharmr.2025.100072_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2020.109889","article-title":"Cross your heart? Collagen cross-links in cardiac health and disease","volume":"79","author":"Neff","year":"2021","journal-title":"Cell Signal"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib37","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.1858","article-title":"Epidemiology of heart failure","volume":"22","author":"Groenewegen","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib38","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"324","author":"Murphy","year":"2020","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib39","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jacc.2020.11.022","volume":"77","author":"Writing Committee","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"10258","key":"10.1016\/j.pharmr.2025.100072_bib40","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib41","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","article-title":"Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration","volume":"365","author":"Talman","year":"2016","journal-title":"Cell Tissue Res"},{"issue":"7921","key":"10.1016\/j.pharmr.2025.100072_bib42","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/s41586-022-04817-8","article-title":"Single-nucleus profiling of human dilated and hypertrophic cardiomyopathy","volume":"608","author":"Chaffin","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100072_bib43","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43882","article-title":"Single-cell expression profiling reveals dynamic flux of cardiac stromal, vascular and immune cells in health and injury","volume":"8","author":"Farbehi","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.pharmr.2025.100072_bib44","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.71008","article-title":"Adult mouse fibroblasts retain organ-specific transcriptomic identity","volume":"11","author":"Forte","year":"2022","journal-title":"Elife"},{"issue":"7924","key":"10.1016\/j.pharmr.2025.100072_bib45","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41586-022-05060-x","article-title":"Spatial multi-omic map of human myocardial infarction","volume":"608","author":"Kuppe","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100072_bib46","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.69854","article-title":"Consequences of PDGFRalpha(+) fibroblast reduction in adult murine hearts","volume":"11","author":"Kuwabara","year":"2022","journal-title":"Elife"},{"issue":"25","key":"10.1016\/j.pharmr.2025.100072_bib47","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk8501","article-title":"Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies","volume":"10","author":"Patrick","year":"2024","journal-title":"Sci Adv"},{"issue":"43","key":"10.1016\/j.pharmr.2025.100072_bib48","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1093\/eurheartj\/ehac095","article-title":"Single-cell technologies to decipher cardiovascular diseases","volume":"43","author":"Abplanalp","year":"2022","journal-title":"Eur Heart J"},{"issue":"13","key":"10.1016\/j.pharmr.2025.100072_bib49","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCULATIONAHA.123.066298","article-title":"Versican promotes cardiomyocyte proliferation and cardiac repair","volume":"149","author":"Feng","year":"2024","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib50","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1038\/s41467-022-30682-0","article-title":"Mapping the cardiac vascular niche in heart failure","volume":"13","author":"Peisker","year":"2022","journal-title":"Nat Commun"},{"issue":"15","key":"10.1016\/j.pharmr.2025.100072_bib51","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/CIRCULATIONAHA.119.045115","article-title":"High-resolution transcriptomic profiling of the heart during chronic stress reveals cellular drivers of cardiac fibrosis and hypertrophy","volume":"142","author":"McLellan","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib52","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.stem.2011.10.002","article-title":"Adult cardiac-resident MSC-like stem cells with a proepicardial origin","volume":"9","author":"Chong","year":"2011","journal-title":"Cell Stem Cell"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib53","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the identity of cardiac fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib54","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/j.stem.2022.07.006","article-title":"Wound healing, fibroblast heterogeneity, and fibrosis","volume":"29","author":"Talbott","year":"2022","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmr.2025.100072_bib55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.matbio.2018.02.020","article-title":"Therapeutic approaches to control tissue repair and fibrosis: extracellular matrix as a game changer","volume":"71-72","author":"Walraven","year":"2018","journal-title":"Matrix Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib56","doi-asserted-by":"crossref","first-page":"6652","DOI":"10.1038\/s41598-020-63671-8","article-title":"Mesenchymal-endothelial transition-derived cells as a potential new regulatory target for cardiac hypertrophy","volume":"10","author":"Dong","year":"2020","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib57","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.stem.2016.10.005","article-title":"Cardiac fibroblasts adopt osteogenic fates and can be targeted to attenuate pathological heart calcification","volume":"20","author":"Pillai","year":"2017","journal-title":"Cell Stem Cell"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib58","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.stem.2019.12.008","article-title":"Pathogenic potential of Hic1-expressing cardiac stromal progenitors","volume":"26","author":"Soliman","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.pharmr.2025.100072_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/7174127","article-title":"Metallothioneins 1 and 2 modulate inflammation and support remodeling in ischemic cardiomyopathy in mice","volume":"2016","author":"Duerr","year":"2016","journal-title":"Mediators Inflamm"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib60","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1172\/JCI98215","article-title":"Specialized fibroblast differentiated states underlie scar formation in the infarcted mouse heart","volume":"128","author":"Fu","year":"2018","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib61","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.stem.2021.10.009","article-title":"Hif-1a suppresses ROS-induced proliferation of cardiac fibroblasts following myocardial infarction","volume":"29","author":"Janbandhu","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib62","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1038\/s41467-022-32284-2","article-title":"Spatiotemporal dynamics of macrophage heterogeneity and a potential function of Trem2(hi) macrophages in infarcted hearts","volume":"13","author":"Jung","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib63","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1038\/s41467-022-30630-y","article-title":"Cardiac fibroblasts regulate the development of heart failure via Htra3-TGF-beta-IGFBP7 axis","volume":"13","author":"Ko","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100072_bib64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib65","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1161\/CIRCULATIONAHA.109.865154","article-title":"Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells","volume":"120","author":"Nelson","year":"2009","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib66","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13287-020-01811-7","article-title":"Cardiac repair in a murine model of myocardial infarction with human induced pluripotent stem cell-derived cardiomyocytes","volume":"11","author":"Jiang","year":"2020","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib67","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1152\/physiolgenomics.00033.2003","article-title":"Developmental anatomy of the heart: a tale of mice and man","volume":"15","author":"Wessels","year":"2003","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharmr.2025.100072_bib68","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pharmthera.2017.10.001","article-title":"The immature electrophysiological phenotype of iPSC-CMs still hampers in vitro drug screening: special focus on I(K1)","volume":"183","author":"Goversen","year":"2018","journal-title":"Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib69","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1253\/circj.CJ-12-0987","article-title":"Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture","volume":"77","author":"Kamakura","year":"2013","journal-title":"Circ J"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100072_bib70","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.stemcr.2019.08.013","article-title":"Fatty acids enhance the maturation of cardiomyocytes derived from human pluripotent stem cells","volume":"13","author":"Yang","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.pharmr.2025.100072_bib71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2019.10.001","article-title":"Enhancement of human iPSC-derived cardiomyocyte maturation by chemical conditioning in a 3D environment","volume":"138","author":"Huang","year":"2020","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib72","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/stem.2732","article-title":"Passive stretch induces structural and functional maturation of engineered heart muscle as predicted by computational modeling","volume":"36","author":"Abilez","year":"2018","journal-title":"Stem Cells"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib73","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1016\/j.biomaterials.2013.12.052","article-title":"The effect of cyclic stretch on maturation and 3D tissue formation of human embryonic stem cell-derived cardiomyocytes","volume":"35","author":"Mihic","year":"2014","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100072_bib74","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.bpj.2018.08.050","article-title":"Effect of substrate stiffness on mechanical coupling and force propagation at the infarct boundary","volume":"115","author":"Nguyen","year":"2018","journal-title":"Biophys J"},{"issue":"21","key":"10.1016\/j.pharmr.2025.100072_bib75","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.1007\/s00018-019-03212-3","article-title":"Molecular determinants of mesenchymal cell activation in fibroproliferative diseases","volume":"76","author":"Penke","year":"2019","journal-title":"Cell Mol Life Sci"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185125","article-title":"Biochemical and biomechanical properties of the pacemaking sinoatrial node extracellular matrix are distinct from contractile left ventricular matrix","volume":"12","author":"Gluck","year":"2017","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib77","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1016\/j.cell.2021.04.034","article-title":"Cardioids reveal self-organizing principles of human cardiogenesis","volume":"184","author":"Hofbauer","year":"2021","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.pharmr.2025.100072_bib78","doi-asserted-by":"crossref","first-page":"5587","DOI":"10.1016\/j.cell.2023.10.030","article-title":"Multi-chamber cardioids unravel human heart development and cardiac defects","volume":"186","author":"Schmidt","year":"2023","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib79","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.120030","article-title":"Initiating head development in mouse embryos: integrating signalling and transcriptional activity","volume":"2","author":"Arkell","year":"2012","journal-title":"Open Biol"},{"issue":"18","key":"10.1016\/j.pharmr.2025.100072_bib80","doi-asserted-by":"crossref","DOI":"10.1242\/dev.160945","article-title":"Divergent early mesoderm specification underlies distinct head and trunk muscle programmes in vertebrates","volume":"145","author":"Nandkishore","year":"2018","journal-title":"Development"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96815-5","article-title":"Comparison of the antiremodeling effects of losartan and mirabegron in a rat model of uremic cardiomyopathy","volume":"11","author":"Kov\u00e1cs","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.pharmr.2025.100072_bib82","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/164_2016_77","article-title":"Sacubitril\/valsartan (LCZ696) in heart failure","volume":"243","author":"Khder","year":"2017","journal-title":"Handb Exp Pharmacol"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib83","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41419-020-2542-9","article-title":"The therapeutic potential of mesenchymal stem cells for cardiovascular diseases","volume":"11","author":"Guo","year":"2020","journal-title":"Cell Death Dis"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib84","doi-asserted-by":"crossref","first-page":"132","DOI":"10.2302\/kjm.54.132","article-title":"Multipotential differentiation of adipose tissue-derived stem cells","volume":"54","author":"Strem","year":"2005","journal-title":"Keio J Med"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100072_bib85","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/stem.169","article-title":"Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction","volume":"27","author":"Mias","year":"2009","journal-title":"Stem Cells"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib86","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3727\/096368912X659871","article-title":"Comparison of human adipose-derived stem cells and bone marrow-derived stem cells in a myocardial infarction model","volume":"23","author":"Rasmussen","year":"2014","journal-title":"Cell Transplant"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib87","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3727\/096368911X623862","article-title":"Adipose stromal vascular fraction improves cardiac function in chronic myocardial infarction through differentiation and paracrine activity","volume":"21","author":"Mazo","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/j.pharmr.2025.100072_bib88","article-title":"Targeting immune-fibroblast crosstalk in myocardial infarction and cardiac fibrosis","author":"Amrute","year":"2023","journal-title":"Res Sq"},{"issue":"8038","key":"10.1016\/j.pharmr.2025.100072_bib89","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","article-title":"Targeting immune-fibroblast cell communication in heart failure","volume":"635","author":"Amrute","year":"2024","journal-title":"Nature"},{"issue":"18","key":"10.1016\/j.pharmr.2025.100072_bib90","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.jacc.2019.02.049","article-title":"Myofibroblast phenotype and reversibility of fibrosis in patients with end-stage heart failure","volume":"73","author":"Nagaraju","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib91","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1038\/s41591-021-01452-0","article-title":"Pirfenidone in heart failure with preserved ejection fraction: a randomized phase 2 trial","volume":"27","author":"Lewis","year":"2021","journal-title":"Nat Med"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100072_bib92","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41573-020-0070-z","article-title":"Targeting the Hippo pathway in cancer, fibrosis, wound healing and regenerative medicine","volume":"19","author":"Dey","year":"2020","journal-title":"Nat Rev Drug Discov"},{"issue":"34","key":"10.1016\/j.pharmr.2025.100072_bib93","doi-asserted-by":"crossref","first-page":"13839","DOI":"10.1073\/pnas.1313192110","article-title":"Hippo pathway effector Yap promotes cardiac regeneration","volume":"110","author":"Xin","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100072_bib94","doi-asserted-by":"crossref","first-page":"L344","DOI":"10.1152\/ajplung.00300.2014","article-title":"Mechanosignaling through YAP and TAZ drives fibroblast activation and fibrosis","volume":"308","author":"Liu","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib95","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.jacbts.2020.07.009","article-title":"Blockade of fibroblast YAP attenuates cardiac fibrosis and dysfunction through MRTF-A inhibition","volume":"5","author":"Francisco","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"24","key":"10.1016\/j.pharmr.2025.100072_bib96","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022659","article-title":"Hippo pathway effector tead1 induces cardiac fibroblast to cardiomyocyte reprogramming","volume":"10","author":"Singh","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"21-22","key":"10.1016\/j.pharmr.2025.100072_bib97","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1101\/gad.329763.119","article-title":"Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis","volume":"33","author":"Xiao","year":"2019","journal-title":"Genes Dev"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib98","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/cells11091386","article-title":"Properties and functions of fibroblasts and myofibroblasts in myocardial infarction","volume":"11","author":"Venugopal","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.pharmr.2025.100072_bib99","doi-asserted-by":"crossref","DOI":"10.1177\/2040622319862697","article-title":"HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis","volume":"10","author":"Lyu","year":"2019","journal-title":"Ther Adv Chronic Dis"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib100","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.3390\/ijms20061329","article-title":"HDAC inhibitors: therapeutic potential in fibrosis-associated human diseases","volume":"20","author":"Yoon","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib101","article-title":"Epigenetics in hepatocellular carcinoma development and therapy: the tip of the iceberg","volume":"2","author":"Fern\u00e1ndez-Barrena","year":"2020","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib102","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.cell.2018.04.033","article-title":"Time-resolved analysis reveals rapid dynamics and broad scope of the CBP\/p300 acetylome","volume":"174","author":"Weinert","year":"2018","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100072_bib103","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1111\/jcmm.14162","article-title":"Acetyltransferase p300 inhibitor reverses hypertension-induced cardiac fibrosis","volume":"23","author":"Rai","year":"2019","journal-title":"J Cell Mol Med"},{"issue":"18","key":"10.1016\/j.pharmr.2025.100072_bib104","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017176","article-title":"Histone acetyltransferase p300 inhibitor improves coronary flow reserve in SIRT3 (Sirtuin 3) knockout mice","volume":"9","author":"Su","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib105","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.3390\/ijms160511482","article-title":"Anti-fibrotic effects of class I HDAC inhibitor, mocetinostat is associated with IL-6\/Stat3 signaling in ischemic heart failure","volume":"16","author":"Nural-Guvener","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pharmr.2025.100072_bib106","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1755-1536-7-10","article-title":"HDAC class I inhibitor, Mocetinostat, reverses cardiac fibrosis in heart failure and diminishes CD90+ cardiac myofibroblast activation","volume":"7","author":"Nural-Guvener","year":"2014","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib107","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.celrep.2016.06.074","article-title":"Signal-dependent recruitment of BRD4 to cardiomyocyte super-enhancers is suppressed by a microRNA","volume":"16","author":"Stratton","year":"2016","journal-title":"Cell Rep"},{"key":"10.1016\/j.pharmr.2025.100072_bib108","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.yjmcc.2013.07.017","article-title":"BET acetyl-lysine binding proteins control pathological cardiac hypertrophy","volume":"63","author":"Spiltoir","year":"2013","journal-title":"J Mol Cell Cardiol"},{"issue":"390","key":"10.1016\/j.pharmr.2025.100072_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aah5084","article-title":"BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure","volume":"9","author":"Duan","year":"2017","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib110","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12933-020-01199-x","article-title":"Apabetalone and hospitalization for heart failure in patients following an acute coronary syndrome: a prespecified analysis of the BETonMACE study","volume":"20","author":"Nicholls","year":"2021","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib111","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2215\/CJN.16751020","article-title":"Effect of apabetalone on cardiovascular events in diabetes, CKD, and recent acute coronary syndrome: results from the BETonMACE Randomized Controlled Trial","volume":"16","author":"Kalantar-Zadeh","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib112","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1159\/000493672","article-title":"Inhibition of histone deacetylases prevents cardiac remodeling after myocardial infarction by restoring autophagosome processing in cardiac fibroblasts","volume":"49","author":"Wang","year":"2018","journal-title":"Cell Physiol Biochem"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib113","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s13577-021-00625-w","article-title":"Histone methyltransferase DOT1L mediates the TGF-beta1\/Smad3 signaling pathway through epigenetic modification of SYK in myocardial infarction","volume":"35","author":"Li","year":"2022","journal-title":"Hum Cell"},{"issue":"6576","key":"10.1016\/j.pharmr.2025.100072_bib114","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"issue":"23","key":"10.1016\/j.pharmr.2025.100072_bib115","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.139445","article-title":"Smooth muscle-derived progenitor cell myofibroblast differentiation through KLF4 downregulation promotes arterial remodeling and fibrosis","volume":"5","author":"Lu","year":"2020","journal-title":"JCI Insight"},{"issue":"7774","key":"10.1016\/j.pharmr.2025.100072_bib116","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib117","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/s42003-021-01747-5","article-title":"RSPO4-CRISPR alleviates liver injury and restores gut microbiota in a rat model of liver fibrosis","volume":"4","author":"Yu","year":"2021","journal-title":"Commun Biol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib118","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1038\/s41467-018-05766-5","article-title":"High-fidelity CRISPR\/Cas9- based gene-specific hydroxymethylation rescues gene expression and attenuates renal fibrosis","volume":"9","author":"Xu","year":"2018","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100072_bib119","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1165\/rcmb.2020-0396OC","article-title":"Spontaneous lung fibrosis resolution reveals novel antifibrotic regulators","volume":"64","author":"Tan","year":"2021","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.pharmr.2025.100072_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121327","article-title":"In vivo therapeutic genome editing via CRISPR\/Cas9 magnetoplexes for myocardial infarction","volume":"281","author":"Park","year":"2022","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib121","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ymthe.2021.10.015","article-title":"CRISPR activation of endogenous genes reprograms fibroblasts into cardiovascular progenitor cells for myocardial infarction therapy","volume":"30","author":"Jiang","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.pharmr.2025.100072_bib122","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.omtn.2020.01.007","article-title":"Transplantation of hMSCs genome edited with LEF1 improves cardio-protective effects in myocardial infarction","volume":"19","author":"Cho","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"10.1016\/j.pharmr.2025.100072_bib123","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nri2343","article-title":"How regulatory T cells work","volume":"8","author":"Vignali","year":"2008","journal-title":"Nat Rev Immunol"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib124","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"T(reg) cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"6656","key":"10.1016\/j.pharmr.2025.100072_bib125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.ade6967","article-title":"In vivo hematopoietic stem cell modification by mRNA delivery","volume":"381","author":"Breda","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.pharmr.2025.100072_bib126","article-title":"Targeted delivery of TGF-beta mRNA to lung parenchyma using one-component ionizable amphiphilic Janus Dendrimers","author":"Atochina-Vasserman","year":"2024","journal-title":"Res Sq"},{"issue":"732","key":"10.1016\/j.pharmr.2025.100072_bib127","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adg6229","article-title":"TGF-betaR2 signaling coordinates pulmonary vascular repair after viral injury in mice and human tissue","volume":"16","author":"Zhao","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pharmr.2025.100072_bib128","first-page":"273","article-title":"Beta-catenin mRNA encapsulated in SM-102 lipid nanoparticles enhances bone formation in a murine tibia fracture repair model","volume":"39","author":"Nelson","year":"2024","journal-title":"Bioact Mater"},{"key":"10.1016\/j.pharmr.2025.100072_bib129","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1278436","article-title":"MicroRNA as a therapeutic target in cardiac remodeling","volume":"2017","author":"Chen","year":"2017","journal-title":"Biomed Res Int"},{"issue":"17","key":"10.1016\/j.pharmr.2025.100072_bib130","first-page":"7611","article-title":"MicroRNA-150 alleviates acute myocardial infarction through regulating cardiac fibroblasts in ventricular remodeling","volume":"23","author":"Tian","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1080\/15384101.2019.1617614","article-title":"MiR-150-5p retards the progression of myocardial fibrosis by targeting EGR1","volume":"18","author":"Shen","year":"2019","journal-title":"Cell Cycle"},{"issue":"21","key":"10.1016\/j.pharmr.2025.100072_bib132","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012880","article-title":"Deficiency of microRNA miR-1954 promotes cardiac remodeling and fibrosis","volume":"8","author":"Chiasson","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib133","first-page":"2229","article-title":"MicroRNA-489 suppresses isoproterenol-induced cardiac fibrosis by downregulating histone deacetylase 2","volume":"19","author":"Yang","year":"2020","journal-title":"Exp Ther Med"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib134","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIRCRESAHA.120.317244","article-title":"Mir-30d regulates cardiac remodeling by intracellular and paracrine signaling","volume":"128","author":"Li","year":"2021","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jcb.29843","article-title":"miR-145 attenuates cardiac fibrosis through the AKT\/GSK-3beta\/beta-catenin signaling pathway by directly targeting SOX9 in fibroblasts","volume":"122","author":"Cui","year":"2021","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.pharmr.2025.100072_bib136","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yjmcc.2013.12.013","article-title":"Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes","volume":"67","author":"Williams","year":"2014","journal-title":"J Mol Cell Cardiol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib137","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1124\/pharmrev.121.000348","article-title":"Interaction of cardiovascular nonmodifiable risk factors, comorbidities and comedications with ischemia\/reperfusion injury and cardioprotection by pharmacological treatments and ischemic conditioning","volume":"75","author":"Ferdinandy","year":"2023","journal-title":"Pharmacol Rev"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib138","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1161\/ATVBAHA.121.316883","article-title":"Single-cell RNA sequencing and assay for transposase-accessible chromatin using sequencing reveals cellular and molecular dynamics of aortic aging in mice","volume":"42","author":"Xie","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.pharmr.2025.100072_bib139","article-title":"Smooth muscle-derived adventitial progenitor cells promote key cell type transitions controlling plaque stability in atherosclerosis in a Klf4-dependent manner","author":"Dubner","year":"2023","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib140","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.stem.2014.11.004","article-title":"Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis","volume":"16","author":"Kramann","year":"2015","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib141","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1038\/s41467-018-06891-x","article-title":"Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels","volume":"9","author":"Dobnikar","year":"2018","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib142","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.stem.2016.08.001","article-title":"Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease","volume":"19","author":"Kramann","year":"2016","journal-title":"Cell Stem Cell"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib143","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.117.312509","article-title":"Single-cell RNA-Seq reveals the transcriptional landscape and heterogeneity of aortic macrophages in murine atherosclerosis","volume":"122","author":"Cochain","year":"2018","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib144","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1161\/ATVBAHA.119.312399","article-title":"Adventitial cell Atlas of wt (wild type) and ApoE (apolipoprotein E)-deficient mice defined by single-cell RNA sequencing","volume":"39","author":"Gu","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"21","key":"10.1016\/j.pharmr.2025.100072_bib145","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1161\/CIRCULATIONAHA.120.046672","article-title":"Stem cell pluripotency genes Klf4 and Oct4 regulate complex SMC phenotypic changes critical in late-stage atherosclerotic lesion pathogenesis","volume":"142","author":"Alencar","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100072_bib146","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1161\/CIRCRESAHA.120.316770","article-title":"Microanatomy of the human atherosclerotic plaque by single-cell transcriptomics","volume":"127","author":"Depuydt","year":"2020","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib147","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.120.045981","article-title":"Environment-sensing aryl hydrocarbon receptor inhibits the chondrogenic fate of modulated smooth muscle cells in atherosclerotic lesions","volume":"142","author":"Kim","year":"2020","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100072_bib148","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/ATVBAHA.120.315373","article-title":"Single-cell transcriptomic atlas of different human cardiac arteries identifies cell types associated with vascular physiology","volume":"41","author":"Hu","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib149","doi-asserted-by":"crossref","DOI":"10.20900\/immunometab20210022","article-title":"Meta-analysis of smooth muscle lineage transcriptomes in atherosclerosis and their relationships to in vitro models","volume":"3","author":"Conklin","year":"2021","journal-title":"Immunometabolism"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100072_bib150","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/ATVBAHA.122.317953","article-title":"Aortic cellular diversity and quantitative genome-wide association study trait prioritization through single-nuclear RNA sequencing of the aneurysmal human aorta","volume":"42","author":"Chou","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100072_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113380","article-title":"Integrative single-cell meta-analysis reveals disease-relevant vascular cell states and markers in human atherosclerosis","volume":"42","author":"Mosquera","year":"2023","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100072_bib152","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/ATVBAHA.123.320524","article-title":"High-dimensional single-cell multimodal landscape of human carotid atherosclerosis","volume":"44","author":"Bashore","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"10.1016\/j.pharmr.2025.100072_bib153","doi-asserted-by":"crossref","DOI":"10.1172\/JCI170246","article-title":"ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts","volume":"134","author":"Hoeft","year":"2024","journal-title":"J Clin Invest"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib154","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112131","article-title":"Platelet-instructed SPP1+ macrophages drive myofibroblast activation in fibrosis in a CXCL4-dependent manner","volume":"42","author":"Hoeft","year":"2023","journal-title":"Cell Rep"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100072_bib155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.it.2019.08.002","article-title":"Adventitial cuffs: regional hubs for tissue immunity","volume":"40","author":"Dahlgren","year":"2019","journal-title":"Trends Immunol"},{"issue":"6438","key":"10.1016\/j.pharmr.2025.100072_bib156","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav2501","article-title":"Identification of a mesenchymal progenitor cell hierarchy in adipose tissue","volume":"364","author":"Merrick","year":"2019","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100072_bib157","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.celrep.2016.02.033","article-title":"Context-dependent development of lymphoid stroma from adult CD34(+) adventitial progenitors","volume":"14","author":"Sitnik","year":"2016","journal-title":"Cell Rep"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib158","doi-asserted-by":"crossref","first-page":"7199","DOI":"10.1038\/s41467-021-27563-3","article-title":"Type-I collagen produced by distinct fibroblast lineages reveals specific function during embryogenesis and Osteogenesis Imperfecta","volume":"12","author":"Chen","year":"2021","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib159","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jacc.2018.09.089","article-title":"Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review","volume":"73","author":"Kovacic","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.pharmr.2025.100072_bib160","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11853","article-title":"Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability","volume":"7","author":"Evrard","year":"2016","journal-title":"Nat Commun"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100072_bib161","first-page":"578","article-title":"SMC switch to fibromyocytes is atheroprotective","volume":"16","author":"Fern\u00e1ndez-Ruiz","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.pharmr.2025.100072_bib162","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-physiol-030212-183802","article-title":"The adventitia: essential regulator of vascular wall structure and function","volume":"75","author":"Stenmark","year":"2013","journal-title":"Annu Rev Physiol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib163","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1161\/ATVBAHA.115.305995","article-title":"Fibroblast angiotensin II type 1a receptors contribute to angiotensin II-induced medial hyperplasia in the ascending aorta","volume":"35","author":"Poduri","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib164","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/ATVBAHA.117.308199","article-title":"Tracking adventitial fibroblast contribution to disease: a review of current methods to identify resident fibroblasts","volume":"37","author":"Kuwabara","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib165","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1161\/01.CIR.103.6.882","article-title":"Mechanisms of neointima formation and remodeling in the porcine coronary artery","volume":"103","author":"Christen","year":"2001","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib166","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/01.CIR.93.12.2178","article-title":"Identification of a potential role for the adventitia in vascular lesion formation after balloon overstretch injury of porcine coronary arteries","volume":"93","author":"Scott","year":"1996","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib167","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1093\/cvr\/cvab174","article-title":"Heterogeneous subpopulations of adventitial progenitor cells regulate vascular homeostasis and pathological vascular remodelling","volume":"118","author":"Jolly","year":"2022","journal-title":"Cardiovasc Res"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib168","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.stemcr.2017.06.011","article-title":"Adventitial SCA-1(+) progenitor cell gene sequencing reveals the mechanisms of cell migration in response to hyperlipidemia","volume":"9","author":"Kokkinopoulos","year":"2017","journal-title":"Stem Cell Rep"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib169","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1172\/JCI19628","article-title":"Abundant progenitor cells in the adventitia contribute to atherosclerosis of vein grafts in ApoE-deficient mice","volume":"113","author":"Hu","year":"2004","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib170","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1161\/ATVBAHA.117.309853","article-title":"Adventitial Sca1+ cells transduced with ETV2 are committed to the endothelial fate and improve vascular remodeling after injury","volume":"38","author":"Le Bras","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib171","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1161\/CIRCRESAHA.116.309322","article-title":"Differentiated smooth muscle cells generate a subpopulation of resident vascular progenitor cells in the adventitia regulated by Klf4","volume":"120","author":"Majesky","year":"2017","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib172","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s42255-020-00338-8","article-title":"Multiple cell types contribute to the atherosclerotic lesion fibrous cap by PDGFRbeta and bioenergetic mechanisms","volume":"3","author":"Newman","year":"2021","journal-title":"Nat Metab"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib173","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1097\/MOL.0000000000000700","article-title":"Fibroblasts in atherosclerosis: heterogeneous and plastic participants","volume":"31","author":"Tillie","year":"2020","journal-title":"Curr Opin Lipidol"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib174","doi-asserted-by":"crossref","first-page":"8683","DOI":"10.1038\/s41598-021-88126-6","article-title":"Contribution of PDGFRalpha-positive cells in maintenance and injury responses in mouse large vessels","volume":"11","author":"Kimura","year":"2021","journal-title":"Sci Rep"},{"issue":"7693","key":"10.1016\/j.pharmr.2025.100072_bib175","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature25739","article-title":"A molecular atlas of cell types and zonation in the brain vasculature","volume":"554","author":"Vanlandewijck","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.pharmr.2025.100072_bib176","article-title":"Targeting modulated vascular smooth muscle cells in atherosclerosis via FAP-directed immunotherapy. Preprint. Posted online","author":"Amrute","year":"2025","journal-title":"bioRxiv"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib177","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/s41591-019-0541-0","article-title":"A protective smooth muscle cell transition in atherosclerosis","volume":"25","author":"Pan","year":"2019","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib178","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s44161-023-00405-9","article-title":"Suppression of IL-1beta promotes beneficial accumulation of fibroblast-like cells in atherosclerotic plaques in clonal hematopoiesis","volume":"3","author":"Fidler","year":"2024","journal-title":"Nat Cardiovasc Res"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib179","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12964-023-01185-2","article-title":"ATP purinergic receptor signalling promotes Sca-1(+) cell proliferation and migration for vascular remodelling","volume":"21","author":"Cui","year":"2023","journal-title":"Cell Commun Signal"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib180","doi-asserted-by":"crossref","first-page":"7286","DOI":"10.1038\/s41598-019-43765-8","article-title":"Vasculogenic properties of adventitial Sca-1(+)CD45(+) progenitor cells in mice: a potential source of vasa vasorum in atherosclerosis","volume":"9","author":"Toledo-Flores","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib181","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1096\/fj.05-4702fje","article-title":"Adventitia contribution in vascular tone: insights from adventitia-derived cells in a tissue-engineered human blood vessel","volume":"20","author":"Laflamme","year":"2006","journal-title":"FASEB J"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib182","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1139\/Y10-015","article-title":"Adventitial fibroblasts in vascular structure and function: the role of oxidative stress and beyond","volume":"88","author":"Di Wang","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib183","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ajpath.2019.10.021","article-title":"Recent developments in vascular adventitial pathobiology: the dynamic adventitia as a complex regulator of vascular disease","volume":"190","author":"Tinajero","year":"2020","journal-title":"Am J Pathol"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib184","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1161\/ATVBAHA.117.309859","article-title":"CYLD deubiquitinates nicotinamide adenine dinucleotide phosphate oxidase 4 contributing to adventitial remodeling","volume":"37","author":"Yu","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.pharmr.2025.100072_bib185","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1161\/ATVBAHA.111.231548","article-title":"Myofibroblast-mediated adventitial remodeling: an underestimated player in arterial pathology","volume":"31","author":"Coen","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100072_bib186","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3390\/diagnostics12040871","article-title":"Adventitial fibroblasts in aortic aneurysm: unraveling pathogenic contributions to vascular disease","volume":"12","author":"Mackay","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib187","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1161\/CIRCRESAHA.119.315428","article-title":"T-cell-derived miRNA-214 mediates perivascular fibrosis in hypertension","volume":"126","author":"Nosalski","year":"2020","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100072_bib188","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.7150\/ijbs.93526","article-title":"Regulation of matrix reloading by tumor endothelial marker 1 protects against abdominal aortic aneurysm","volume":"20","author":"Hong","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"6","key":"10.1016\/j.pharmr.2025.100072_bib189","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/HCO.0000000000000216","article-title":"Abdominal aortic aneurysm: novel mechanisms and therapies","volume":"30","author":"Davis","year":"2015","journal-title":"Curr Opin Cardiol"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib190","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/HYPERTENSIONAHA.118.11184","article-title":"PARP-1 (poly[ADP-ribose] polymerase 1) inhibition protects from Ang II (angiotensin II)-induced abdominal aortic aneurysm in mice","volume":"72","author":"Liang","year":"2018","journal-title":"Hypertension"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib191","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7150\/ijbs.83091","article-title":"S100A4 is a key facilitator of thoracic aortic dissection","volume":"20","author":"Shi","year":"2024","journal-title":"Int J Biol Sci"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib192","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13098-022-00966-y","article-title":"miR-132-3p and KLF7 as novel regulators of aortic stiffening-associated EndMT in type 2 diabetes mellitus","volume":"15","author":"Hulshoff","year":"2023","journal-title":"Diabetol Metab Synd.r"},{"issue":"9","key":"10.1016\/j.pharmr.2025.100072_bib193","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1042\/CS20120097","article-title":"Involvement of the renin-angiotensin system in abdominal and thoracic aortic aneurysms","volume":"123","author":"Lu","year":"2012","journal-title":"Clin Sci (Lond)"},{"issue":"17","key":"10.1016\/j.pharmr.2025.100072_bib194","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1152\/physiolgenomics.00044.2011","article-title":"Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm","volume":"43","author":"Spin","year":"2011","journal-title":"Physiol Genomics"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib195","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/eci.12173","article-title":"Role of the renin-angiotensin system on abdominal aortic aneurysms","volume":"43","author":"Malekzadeh","year":"2013","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.pharmr.2025.100072_bib196","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2164-10-298","article-title":"Whole genome expression analysis within the angiotensin II-apolipoprotein E deficient mouse model of abdominal aortic aneurysm","volume":"10","author":"Rush","year":"2009","journal-title":"BMC Genomics"},{"issue":"5","key":"10.1016\/j.pharmr.2025.100072_bib197","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/HYPERTENSIONAHA.116.06375","article-title":"Adventures in the adventitia","volume":"67","author":"Lehoux","year":"2016","journal-title":"Hypertension"},{"issue":"4","key":"10.1016\/j.pharmr.2025.100072_bib198","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/ATVBAHA.112.300036","article-title":"Increased aortic stiffness and attenuated lysyl oxidase activity in obesity","volume":"33","author":"Chen","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib199","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1161\/ATVBAHA.115.306088","article-title":"Adventitia and perivascular cells","volume":"35","author":"Majesky","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100072_bib200","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/s41588-023-01518-4","article-title":"Multi-ancestry genome-wide study identifies effector genes and druggable pathways for coronary artery calcification","volume":"55","author":"Kavousi","year":"2023","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib201","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.stem.2019.11.010","article-title":"Arterial Sca1(+) vascular stem cells generate de novo smooth muscle for artery repair and regeneration","volume":"26","author":"Tang","year":"2020","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib202","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s42003-024-06087-8","article-title":"Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions","volume":"7","author":"Boelaars","year":"2024","journal-title":"Commun Biol"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2023.100820","article-title":"Cardiovascular disease in the older adult: where are we 4 decades later?","volume":"3","author":"Forouzandeh","year":"2024","journal-title":"JACC Adv"},{"issue":"12","key":"10.1016\/j.pharmr.2025.100072_bib204","first-page":"1795","article-title":"Recent advances in understanding the molecular pathophysiology of angiotensin II receptors: lessons from cell-selective receptor deletion in mice","volume":"39","author":"Eguchi","year":"2023","journal-title":"Can J Cardiol"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100072_bib205","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/ATVBAHA.117.309863","article-title":"Deletion of NF-kappaB\/RelA in angiotensin II-sensitive mesenchymal cells blocks aortic vascular inflammation and abdominal aortic aneurysm formation","volume":"37","author":"Ijaz","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"21","key":"10.1016\/j.pharmr.2025.100072_bib206","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.148382","article-title":"Complement-containing small extracellular vesicles from adventitial fibroblasts induce proinflammatory and metabolic reprogramming in macrophages","volume":"6","author":"Kumar","year":"2021","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.pharmr.2025.100072_bib207","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/ATVBAHA.120.315322","article-title":"Fibroblast Nox2 (NADPH oxidase-2) regulates ANG II (angiotensin II)-induced vascular remodeling and hypertension via paracrine signaling to vascular smooth muscle cells","volume":"41","author":"Harrison","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"15","key":"10.1016\/j.pharmr.2025.100072_bib208","doi-asserted-by":"crossref","DOI":"10.1172\/JCI131178","article-title":"Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype","volume":"131","author":"Lecce","year":"2021","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib209","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1038\/s41467-022-30633-9","article-title":"Identification, discrimination and heterogeneity of fibroblasts","volume":"13","author":"Lendahl","year":"2022","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib210","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1038\/s41467-021-24110-y","article-title":"Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases","volume":"12","author":"Deng","year":"2021","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib211","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1038\/s41467-020-17740-1","article-title":"Single-cell analysis uncovers fibroblast heterogeneity and criteria for fibroblast and mural cell identification and discrimination","volume":"11","author":"Muhl","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.pharmr.2025.100072_bib212","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ajpath.2011.06.001","article-title":"Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders","volume":"179","author":"Piera-Velazquez","year":"2011","journal-title":"Am J Pathol"},{"issue":"7524","key":"10.1016\/j.pharmr.2025.100072_bib213","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nature13839","article-title":"Mesenchymal-endothelial transition contributes to cardiac neovascularization","volume":"514","author":"Ubil","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.pharmr.2025.100072_bib214","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13287-023-03256-0","article-title":"Single cell and lineage tracing studies reveal the impact of CD34(+) cells on myocardial fibrosis during heart failure","volume":"14","author":"Du","year":"2023","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib215","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/s12276-024-01309-9","article-title":"Altered lipid metabolism promoting cardiac fibrosis is mediated by CD34(+) cell-derived FABP4(+) fibroblasts","volume":"56","author":"Du","year":"2024","journal-title":"Exp Mol Med"},{"issue":"8","key":"10.1016\/j.pharmr.2025.100072_bib216","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIRCRESAHA.121.319494","article-title":"Nonbone marrow CD34(+) cells are crucial for endothelial repair of injured artery","volume":"129","author":"Jiang","year":"2021","journal-title":"Circ Res"},{"issue":"19","key":"10.1016\/j.pharmr.2025.100072_bib217","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"issue":"9386","key":"10.1016\/j.pharmr.2025.100072_bib218","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.pharmr.2025.100072_bib219","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.pharmr.2025.100072_bib220","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1161\/01.CIR.0000028335.31300.DA","article-title":"Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) trial","volume":"106","author":"Holmes","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.pharmr.2025.100072_bib221","article-title":"Effect of dapagliflozin on indicators of myocardial fibrosis and levels of inflammatory factors in heart failure patients","volume":"2022","author":"Wang","year":"2022","journal-title":"Dis Markers"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725074800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699725074800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T23:10:06Z","timestamp":1759965006000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699725074800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":221,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0031699725074800"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100072","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fibroblasts\u2014The emerging therapeutic target of the cardiovascular system?","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmr.2025.100072","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc. on behalf of American Society for Pharmacology and Experimental Therapeutics.","name":"copyright","label":"Copyright"}],"article-number":"100072"}}